Delivery Order SPE2DB20D3303-SPE2DB25FA1KV
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,493.20 firm fixed price delivery order is for the supply of Risperdal 0.5 mg tablets, a pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, designated as SPE2DX. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,668.11 firm fixed-price delivery order is for the supply of Risperdal 0.5 mg tablets, with a completion date of November 16, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award is a delivery order with a firm fixed price valued at $1,836.79, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of 4568618256 - RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Risperdal 1 mg tablets, a mental health medication, for $1,023.97. The contract has a period of performance ending on June 30, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,058.81, is for the delivery of 4564541366 RISPERDAL 1 MG TABLET 60S through May 9, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of RISPERDAL 0.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $3,703.55 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 14, 2023. Amerisourcebergen is the prime contractor and does not have any listed subcontractors. The award is associated with a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERDAL 3 MG TABLET 60S, a prescription medication, with a firm fixed price of $1,004.68 and a completion date of July 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.38 firm-fixed-price contract is for the delivery of RISPERDAL 0.5 MG TABLET 60S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 0.5 mg tablets, with a ceiling value of $1,679.94 and an ultimate completion date of May 29, 2025. The contract is a Firm Fixed Price (FFP) arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $24,869.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1KVDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,062.01 Firm Fixed Price delivery order contract is for the supply of RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025 and was awarded on July 16, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which runs through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/16/25 |